Global Poultry Vaccines Market Projected to Reach $3 Billion by 2030 at 9.5% CAGR

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Anti-Neoplastic Agents Market By The End Of 2030?

The poultry vaccines market size has demonstrated strong growth in recent years. It is forecast to expand from $1.94 billion in 2025 to $2.12 billion in 2026, at a compound annual growth rate (CAGR) of 9.4%. The historical growth can be attributed to factors like outbreaks of avian diseases, increasing poultry consumption, the development of traditional vaccines, rising farm-level veterinary awareness, and the expansion of commercial poultry farming.

The poultry vaccines market size is anticipated to experience substantial growth in the coming years. It will expand to **$3.04 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%.** The expansion during this forecast period is attributable to the increasing development of recombinant and DNA vaccines, the adoption of precise poultry vaccination programs, technological improvements in vaccine delivery systems, government initiatives aimed at poultry health, and a rising focus on biosecurity measures within poultry farms. Significant trends expected during the forecast period include the greater use of live and inactivated poultry vaccines, an emphasis on preventing diseases in broilers and layers, the broader application of recombinant and DNA vaccines, the integration of vaccination strategies with general farm management practices, and the enhancement of cold chain infrastructure for distributing poultry vaccines.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8622&type=smp

Which Market Drivers Are Supporting The Expansion Of The Anti-Neoplastic Agents Market?

The rising occurrence of zoonotic diseases is projected to boost the expansion of the poultry vaccine market moving forward. Zoonotic diseases encompass a range of common illnesses caused by pathogenic microorganisms such as viruses, bacteria, parasites, and fungi. The heightened incidence of zoonotic diseases is increasing due to greater human–animal interaction, as expanding urbanization and livestock farming bring people and animals into closer contact. The poultry vaccine market addresses the increasing prevalence of zoonotic diseases, with escalating disease risks prompting the necessity for vaccination to prevent the spread of infections from poultry to humans and ensure the health of flocks. For instance, in December 2025, according to European Centre for Disease Prevention and Control, a Sweden-based government agency, in 2024, the five most reported zoonoses in humans were campylobacteriosis, with 168,396 cases (55.3 cases per 100,000 people), salmonellosis, with 79,703 cases (18.6 cases per 100,000 people), Shiga toxin-producing Escherichia coli (STEC) infections, with 11,738 cases (3.5 cases per 100,000 people) and echinococcosis, with 984 cases (0.22 cases per 100,000 people). Consequently, the growing prevalence of zoonotic diseases is anticipated to drive the growth of poultry vaccines.

Which Segment Classifications Shape The Anti-Neoplastic Agents Market?

The poultry vaccines market covered in this report is segmented –

1) By Type: Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion Animal Vaccine, Aquaculture Vaccines, Other Animal Vaccines

2) By Disease Type: Avain Influenza, Infectious Bronchitis

3) By Dosage Form: Liquid Vaccine, Freeze Dried Vaccine, Duct

4) By Technology: Toxoid, Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines

5) By Application: Broiler, Layer, Breeder

Subsegments:

1) By Porcine Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, DNA Vaccines, Recombinant Vaccines, Toxoid Vaccines

2) By Poultry Vaccines: Live Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines, DNA Vaccines

3) By Livestock Vaccines: Bovine Vaccines, Swine Vaccines, Ovine Vaccines

4) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Ferret Vaccines

5) By Aquaculture Vaccines: Fish Vaccines, Shrimp Vaccines

6) By Other Animal Vaccines: Wildlife Vaccines, Exotic Animal Vaccines

How Are Trends Impacting The Poultry Vaccines Market?

Major companies operating in the poultry vaccine market are intensifying efforts to develop advanced technological solutions to solidify their market position. These innovative solutions include sophisticated vaccine formulations, enhanced delivery systems, and cutting-edge diagnostic tools, all engineered to improve disease prevention, boost efficacy, and optimize poultry health management. For instance, in October 2023, Zoetis Inc., a US-based animal health company, introduced Circomax. This porcine circovirus type 2 (PCV2) vaccine comes in two genotypes, a and b. The vaccination aims to protect against PCV2 risks, such as the three genotypes identified in the UK pig herd, and to provide broader coverage. This particular PCV2 vaccination is the only one licensed to offer protection against all three genotypes, having demonstrated its efficacy against PCV2a, PCV2b, and PCV2d. With the debut of CircoMax, Zoetis is striving to stay ahead of the PCV2 genotype evolution and deliver high levels of efficacy, convenience, and proven safety for healthy piglets.

Which Companies Are Expanding Their Footprint In The Anti-Neoplastic Agents Market?

Major companies operating in the poultry vaccines market are Merck & Co Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Ringpu Biology, MSD Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale S.A., Phibro Animal Health Corporation, Huvepharma AD, Venkys India Limited, Vetoquinol S.A., Indian Immunologicals Limited, Vaccination Services Pvt Ltd., Indovax Private Limited, Bio-Vet Inc., Hester Biosciences Limited, Intervet Inc., Anicon Labor GmbH, CZ Veterinaria S.A., Bioproperties Pty Ltd, Bioveta a.s., Aptimmune Biologics Inc., HIPRA S.A., Biovac (Pty) Ltd., Nisseiken Co Ltd., Zydus Animal Health Limited, Jinyu Bio-Technology Co Ltd., Kyoto Biken Laboratories Inc.

Read the full poultry vaccines market report here:

https://www.thebusinessresearchcompany.com/report/poultry-vaccines-global-market-report

How Is The Anti-Neoplastic Agents Market Distributed Across Key Geographic Regions?

North America was the largest region in the poultry vaccines market in 2025. The regions covered in the poultry vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Anti-Neoplastic Agents Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8622&type=smp

Browse Through More Reports Similar to the Global Poultry Vaccines Market 2026, By The Business Research Company

Veterinary Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Chickenpox Vaccine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/chickenpox-vaccine-global-market-report

Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795